NV Bekaert SA
XBRU:BEKB
NV Bekaert SA
XBRU:BEKB
Price:
41.55
EUR
-2%
Market Closed
Market Cap:
€2.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
NV Bekaert SA
XBRU:BEKB
|
BE |
|
Cemedine Co Ltd
TSE:4999
|
JP |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
|
CN |
|
F
|
Fujian Green Pine Co Ltd
SZSE:300132
|
CN |
|
Graco Inc
NYSE:GGG
|
US |
|
Sendas Distribuidora SA
BOVESPA:ASAI3
|
BR |
|
L
|
Lila Kagit Sanayi ve Ticaret AS
IST:LILAK.E
|
TR |
|
Tangrenshen Group Co Ltd
SZSE:002567
|
CN |
Income Statement
Earnings Waterfall
NV Bekaert SA
NV Bekaert SA
Income Statement
NV Bekaert SA
NV Bekaert SA
Currency: EUR
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Interest Expense |
64
|
60
|
55
|
44
|
36
|
34
|
39
|
40
|
39
|
38
|
36
|
32
|
|
| Revenue |
3 874
N/A
|
3 772
-3%
|
4 309
+14%
|
4 840
+12%
|
5 057
+4%
|
5 004
-1%
|
4 798
-4%
|
4 328
-10%
|
4 070
-6%
|
3 958
-3%
|
3 851
-3%
|
3 706
-4%
|
|
| Gross Profit | |||||||||||||
| Cost of Revenue |
(3 343)
|
(3 171)
|
(3 487)
|
(3 935)
|
(4 214)
|
(4 255)
|
(4 052)
|
(3 583)
|
(3 354)
|
(3 274)
|
(3 221)
|
(3 114)
|
|
| Gross Profit |
531
N/A
|
601
+13%
|
822
+37%
|
905
+10%
|
844
-7%
|
749
-11%
|
746
0%
|
745
0%
|
716
-4%
|
684
-4%
|
630
-8%
|
592
-6%
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(325)
|
(309)
|
(338)
|
(426)
|
(359)
|
(348)
|
(360)
|
(354)
|
(345)
|
(346)
|
(326)
|
(295)
|
|
| Selling, General & Administrative |
(283)
|
(286)
|
(312)
|
(356)
|
(339)
|
(302)
|
(310)
|
(307)
|
(301)
|
(300)
|
(280)
|
(256)
|
|
| Research & Development |
(54)
|
(50)
|
(54)
|
(59)
|
(58)
|
(62)
|
(65)
|
(55)
|
(53)
|
(53)
|
(52)
|
(49)
|
|
| Depreciation & Amortization |
0
|
(2)
|
0
|
(2)
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
12
|
28
|
28
|
(9)
|
38
|
16
|
14
|
8
|
9
|
7
|
6
|
10
|
|
| Operating Income |
206
N/A
|
292
+41%
|
484
+66%
|
479
-1%
|
484
+1%
|
401
-17%
|
386
-4%
|
391
+1%
|
370
-5%
|
338
-9%
|
303
-10%
|
297
-2%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
(61)
|
(80)
|
(51)
|
(31)
|
(32)
|
(34)
|
(30)
|
(52)
|
(48)
|
(23)
|
(21)
|
(37)
|
|
| Non-Reccuring Items |
(79)
|
(34)
|
(27)
|
30
|
(13)
|
(83)
|
(96)
|
(56)
|
(64)
|
(41)
|
(83)
|
(162)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(33)
|
(7)
|
(11)
|
(5)
|
19
|
(6)
|
(49)
|
(14)
|
0
|
(15)
|
(23)
|
(12)
|
|
| Pre-Tax Income |
34
N/A
|
170
+406%
|
395
+132%
|
474
+20%
|
457
-4%
|
278
-39%
|
211
-24%
|
268
+27%
|
258
-4%
|
258
0%
|
176
-32%
|
86
-51%
|
|
| Net Income | |||||||||||||
| Tax Provision |
(42)
|
(57)
|
(104)
|
(134)
|
(112)
|
(74)
|
(70)
|
(62)
|
(62)
|
(63)
|
(51)
|
(59)
|
|
| Income from Continuing Operations |
(9)
|
114
|
291
|
340
|
345
|
203
|
141
|
206
|
196
|
195
|
125
|
26
|
|
| Income to Minority Interest |
(4)
|
(13)
|
(36)
|
(44)
|
(35)
|
(20)
|
(22)
|
2
|
15
|
(5)
|
(3)
|
3
|
|
| Equity Earnings Affiliates |
29
|
34
|
55
|
108
|
103
|
54
|
48
|
47
|
44
|
49
|
52
|
38
|
|
| Net Income (Common) |
(9)
N/A
|
135
N/A
|
208
+54%
|
404
+94%
|
433
+7%
|
269
-38%
|
193
-28%
|
255
+32%
|
240
-6%
|
239
0%
|
174
-27%
|
67
-61%
|
|
| EPS (Diluted) |
-0.15
N/A
|
2.1
N/A
|
3.62
+72%
|
7.01
+94%
|
7.52
+7%
|
4.74
-37%
|
3.54
-25%
|
4.72
+33%
|
4.55
-4%
|
4.55
N/A
|
3.38
-26%
|
1.33
-61%
|
|
Switch to:
Switch to:
See Also
Discover More
